Literature DB >> 7887711

Overview of the nature of vasoconstriction in arterial grafts for coronary operations.

G W He1, C Q Yang, A Starr.   

Abstract

Many vasoconstrictors (spasmogens) may cause arterial graft spasm; however, there is lack of an overview of the nature of vasoconstriction in grafts. This study was designed to investigate the response of three major arterial grafts currently used for coronary artery bypass grafting to various vasoconstrictor substances. Segments of three arterial grafts (gastroepiploic [GEA], n = 28; internal mammary [IMA], n = 213; inferior epigastric [IEA], n = 24) taken from patients undergoing coronary artery bypass grafting were studied in organ baths under a physiologic pressure. Cumulative concentration-contraction curves were established for the following vasoconstrictor substances: endothelin-1, U46619, prostaglandin F2 alpha, norepinephrine, methoxamine, phenylephrine, 5-hydroxytryptamine, and potassium chloride (K+). In IMA, the highest contraction force was induced by U46619 (5.69 +/- 0.48 g), endothelin-1 (4.43 +/- 0.4 g), PGF2 alpha (6.29 +/- 1.42 g), and K+ (4.58 +/- 0.5 g). Internal mammary artery is highly sensitive to endothelin-1 (EC50, -8.13 +/- 0.08 log M) and U46619 (EC50, -8.21 +/- 0.21 log M) (lower than any other vasoconstrictors, p < 0.001). Next sensitive vasoconstrictors were PGF2 alpha and norepinephrine. 5-Hydroxytryptamine induced significantly higher contraction force in the IMA without endothelium (2.8 +/- 0.64 g versus 1.4 +/- 0.23 g, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887711     DOI: 10.1016/0003-4975(94)01011-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.

Authors:  Z Ren; S Floten; A Furnary; M Liu; H Gately; J Swanson; A Ahmad; A P Yim; G W He
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  Pedicled or skeletonized? A review of the internal thoracic artery graft.

Authors:  Carlos Del Campo
Journal:  Tex Heart Inst J       Date:  2003

3.  Both skeletonized and pedicled internal thoracic arteries supply adequate graft flow after coronary artery bypass grafting even during intense sympathoexcitation.

Authors:  Dai Une; Shuji Shimizu; Atsunori Kamiya; Toru Kawada; Toshiaki Shishido; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2010-09-14       Impact factor: 2.781

4.  Arterial grafts: clinical classification and pharmacological management.

Authors:  Guo-Wei He
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 5.  Thirty-year experience with bilateral internal thoracic artery grafting: where have we been and where are we going?

Authors:  Paul Kurlansky
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

6.  Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery.

Authors:  T J Batchelor; J R Sadaba; A Ishola; P Pacaud; C M Munsch; D J Beech
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.

Authors:  G W He; C Q Yang
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

8.  Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.

Authors:  M H Liu; S H Floten; Q Yang; G W He
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

9.  Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery.

Authors:  G W He; C Q Yang
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

10.  The sources of calcium for noradrenaline-induced contraction in the human thoracic internal artery.

Authors:  Leszek Buzun; Beata Modzelewska; Anna Kostrzewska; Ewa Kleszczewska; Tomasz Kleszczewski
Journal:  Pflugers Arch       Date:  2017-04-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.